Dupilumab May Lower Exacerbation Rates in Allergic Bronchopulmonary Aspergillosis
In a post hoc analysis of the LIBERTY ASTHMA QUEST study, researchers found that dupilumab may reduce exacerbations in patients with allergic bronchopulmonary aspergillosis.